Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk

Sanofi acquires Dynavax for $2.2B, boosting its vaccine portfolio with HEPLISAV-B and a shingles candidate. Click for my ...
The Manila Times on MSN

Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal

SANOFI said on Wednesday it will buy US biotech Dynavax Technologies for around $2.2 billion (1.9 billion euros) in an agreed deal that will add an adult hepatitis B vaccine and a promising ...

Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger

Dynavax soared by 38.19 percent on Wednesday to close at $15.38 apiece as investors took heart from news that it was set to ...

Asian shares are mixed after US stocks drift to more records

Asian shares were mixed Thursday in thin holiday trading, with most markets in the region and elsewhere closed for ...